Back to search

Article

BBIBP-CorV Vaccination Reduces COVID-19 Severity Rate and Accelerates Anti-Viral Antibody Responses in Heterologous Omicron Infection

2022-07-29

Abstract excerpt

Background: Variants-of-Concern (VOC) of severe respiratory syndrome coronavirus 2 (SARS-CoV-2) are prevailing sequentially worldwide including China. How BBIBP-CorV vaccination affecting dynamic profiles of antibody responses during Omicron epidemic and their associations with clinical outcomes are investigated in this study.<br><br>Methods: We carried out a retrospective study in one of the main COVID-19 referra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f0e1338f-1031-5c1a-af34-0a37888348da
DOI
10.2139/ssrn.4176413
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BBIBP-CorV Vaccination Reduces COVID-19 Severity Rate and Accelerates Anti-Viral Antibody Responses in Heterologous Omicron InfectionDOI 10.2139/ssrn.4176413
Association Between Clinical Manifestations, Outcomes, And Different Vaccination Regimens in Patients with Omicron Breakthrough Infection: A Real-World Cohort StudySemantic proximity
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7): A systematic reviewSemantic proximity
Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort studySemantic proximity
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective studySemantic proximity
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2 in China: A case-control studySemantic proximity
Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periodsSemantic proximity
<strong>Efficacy of COVID-19 Vaccines Against the Omicron Variant of SARS-CoV-2</strong>Semantic proximity
Clinical Characteristics and Outcome of Patients with Sars-Cov-2 Omicron Variant in Shanghai: A Single Center, Retrospective, Observational StudySemantic proximity
Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variantsSemantic proximity
Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera.Semantic proximity
Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in ChinaSemantic proximity
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivitySemantic proximity
Select a neighboring publication to make it the new centre.